Sun Pharma, India's largest drugmaker by revenue, acquired deuruxolitinib when it bought US-based Concert Pharmaceuticals for $576 million earlier this year.
Sun Pharma said FDA has also stated that patients with alopecia areata on 12 mg dose of the drug deuruxolitinib should discontinue its use, Sun Pharma said.
Sun Pharma says nafamostat has shown promise in fighting against the virus in in-vitro studies conducted by 3 groups of scientists in Europe, Japan and South Korea.
Electoral competition now appears dominated by welfare delivery and governance metrics, but ideology has not disappeared in Tamil Nadu. Instead, it has become strategic.
India’s fast-growing data centre sector may strain state electricity networks; Central Electricity Authority has urged Maharashtra, Andhra Pradesh, Telangana and Tamil Nadu to boost capacity.
On lessons from the ongoing West Asia conflict, he says that while US had superior technology and strike capability, Iran used geography to its advantage.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS